EMPAGLYN L 25MG (Empagliflozin (25mg) + Linagliptin (5mg))

Empaglyn L 25/5 Tablet is a combination medication designed to assist in managing blood glucose levels. It is intended for use alongside dietary modifications and physical activity to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus. This medication aids in the effective utilization of insulin, thereby contributing to the reduction of blood sugar concentrations. Patients can take Empaglyn L 25/5 Tablet either with meals or on an empty stomach, at any time during the day; however, it is advisable to take it consistently at the same time daily. The prescribing physician will determine the appropriate dosage. It is crucial not to discontinue the treatment without consulting with your healthcare provider, as doing so could result in elevated blood sugar levels and increase the risk of severe complications such as renal impairment or vision loss. This medication is part of a comprehensive treatment strategy that should also include a balanced diet, regular physical activity, and weight management as per your doctor’s recommendations. Common adverse reactions may include urinary tract infections, nasopharyngitis, and upper respiratory infections. To prevent dehydration, it is important to maintain adequate fluid intake while undergoing this treatment. Some users might encounter fungal infections in the genital area, which can often be mitigated by good hygiene practices. Prior to commencing this medication, it is essential to inform your healthcare provider of any existing kidney or liver issues, urinary tract infections, or if you are taking diuretics. Pregnant or nursing individuals are encouraged to consult their physician before starting this medication. It is also advisable to limit alcohol consumption during treatment, as it can elevate the likelihood of experiencing certain side effects. Regular monitoring of blood glucose levels is recommended while using this medication.